Main Acute Secondary Services across Cheshire and Merseyside

The NHS Cheshire and Merseyside Integrated Care Board has completed the procurement process for "Main Acute Secondary Services across Cheshire and Merseyside", part of the health services industry. The contract, valued at approximately £45,907,556 annually, was awarded under a Direct Award A to the Liverpool Heart and Chest Hospital NHS Foundation Trust for services including acute, cancer, and radiotherapy services, as well as community and screening services. This procurement process followed the Provider Selection Regime (PSR) under the Health Care Services Regulations 2023, and did not apply the Public Contracts Regulations 2015.

The contract commenced on 1st April 2024 and is set to expire on 31st March 2025, predominantly servicing the UKD72 region. This tender presents significant opportunities for service providers involved in the healthcare sector, particularly those specialising in acute and specialist medical services such as radiotherapy and cancer treatment. The NHS Cheshire and Merseyside Integrated Care Board's decision to operate under the PSR highlights the potential for streamlined contracting, which could appeal to organisations with innovative offerings or those that can demonstrate unique capabilities.

Given the criteria employed—focusing on the absence of realistic alternatives—businesses that can showcase an unparalleled ability to deliver specialised health services would be especially suited to compete in similar future tenders. The considerable contract value also indicates potential for business growth and service expansion for providers within this sector.